BioLineRx to Report 2024 Annual Results on March 31, 2025

Go back to BioLineRx to Report 2024 Annual Results on March 31, 2025
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.74 --0 (-0%)
Previous Close $2.74    52 Week High $1.63 
Open $2.74    52 Week Low $0.71 
Day High $2.74    P/E N/A 
Day Low $2.74    EPS $0.00 
Volume 2,346       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.74 --0 (-0%)
Previous Close $2.74    52 Week High $1.63 
Open $2.74    52 Week Low $0.71 
Day High $2.74    P/E N/A 
Day Low $2.74    EPS $0.00 
Volume 2,346